Company Pharmsynthez

Company Pharmsynthez

LIFE

RU000A0JR514

Pharmaceuticals

Equities

LIFE

RU000A0JR514

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per region

Sector Other Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per region

Sector Other Pharmaceuticals

End-of-day quote Moscow Micex - RTS Other stock markets 03:30:00 08/07/2022 am IST			5-day change	1st Jan Change
4.505 ^RUB	+10.15%		-.--%	-.--%

2023	Public Joint-Stock Company "Pharmsynthez" Auditor Raises 'Going Concern' Doubt	CI
2023	Public Joint-Stock Company "Pharmsynthez" Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Farmsintez PAO (Farmsintez OJSC) is a Russia-based company, which is engaged in the pharmaceutical sector. The Company focuses on the medical research, development and manufacture of drugs ingredients used in oncology, gynecology, tuberculosis therapy and others. In addition, Farmsintez OAO offers chemical research services, chemical technology development and quality control services. The Company sells its products domestically, as well as abroad, including the Commonwealth of Independence State (CIS) countries. It has two wholly owned subsidiaries located in Moscow and Tallin, Estonia. As of May 21, 2011, the Companyâs major shareholder was EphaG AS with a stake of 69.23%. In April 2013, the Company acquired the pharmacies of Guardum Pharmaceuticals in the U.S. state of Florida.

RUB in Million	2020	Weight	2021	Weight	Delta
Pharmaceuticals 100.0 %	200	100.0 %	438	100.0 %	+118.81%

RUB in Million	2020	Weight	2021	Weight	Delta
Russia 51.0 %	200	100.0 %	224	51.0 %	+11.64%
Ukraine 12.3 %	-	-	54	12.3 %	-
Latvia 10.8 %	-	-	47	10.8 %	-
United States 7.3 %	-	-	32	7.3 %	-
Estonia 6.5 %	-	-	28	6.5 %	-
Other 6.5 %	-	-	28	6.5 %	-
Kazakhstan 4.1 %	-	-	18	4.1 %	-
Azerbaijan 1.4 %	-	-	6	1.4 %	-
Belarus 0.2 %	-	-	1	0.2 %	-

Managers	Title	Age	Since
Petr Vladimirovich Kruglyakov CEO	Chief Executive Officer	46	01/13/01
Alexey Shafranov DFI	Director of Finance/CFO	45	01/05/01
Dmitriy Nikolayevich Poznyak CTO	Chief Tech/Sci/R&D Officer	-	-
Sergey Avtushenko BRD	Director/Board Member	56	01/07/01
Yuliya Yurievna Yakovleva AUD	Comptroller/Controller/Auditor	53	-
Vladimir Olegovich Kutyrov SAM	Sales & Marketing	57	-
Artem Vladimirovich Orlov LAW	General Counsel	48	01/13/01
Roza Vasilyevna Mikhaylova PRN	Corporate Officer/Principal	-	-
Alexandra Vladimirovna Tuchkova PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Steve Gorelik BRD	Director/Board Member	45	01/07/01
Olga Yuryevna Shpichko BRD	Director/Board Member	49	15/13/15
Sergey Avtushenko BRD	Director/Board Member	56	01/07/01
Alexey Vinogradov BRD	Director/Board Member	54	03/23/03
Roman Sergeevich Knyazev BRD	Director/Board Member	44	15/13/15
Petr Vladimirovich Kruglyakov CEO	Chief Executive Officer	46	01/13/01
Artem Vladimirovich Orlov LAW	General Counsel	48	01/13/01
Pavel Rodyukov BRD	Director/Board Member	-	03/23/03
Sergey Kimovich Bezhanov BRD	Director/Board Member	65	-
Nina Podkolzina BRD	Director/Board Member	50	03/23/03

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	301,010,754	286,608,971 ( 95.22 %)	0	95.22 %

Pharmsynthez PJSC

IT Park Business Center 25Zh, Krasnogo Kursanta Street

197110, St. Petersburg

http://www.pharmsynthez.com

	1st Jan change	Capi.
PHARMSYNTHEZ	-.--%	14.93M
ELI LILLY AND COMPANY	+32.09%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.34%	371B
MERCK & CO., INC.	+20.34%	331B
ABBVIE INC.	+7.39%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+8.49%	169B

Other Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals